CERILLIANT™ Lacosamide-13C, D3 Solution, 100 μg/mL in Acetonitrile, Sold by MilliporeSigma™ Supelco™
Certified reference material
Manufacturer: MilliporeSigma Supelco L0271ML
DescriptionLacosamide is a new antiepileptic drug approved by the FDA in late 2008 for the treatment of partial-onset seizures and diabetic neuropathic pain. The drug is marketed under the trade name Vimpat™. This internal standard is suitable for lacosamide testing methods by LC/MS or GC/MS for clinical toxicology, forensic analysis, or urine drug testing.
|2°C (35.6°F) - closed cup|
|UN 1648 3 / PGII|
|100 μg/mL in acetonitrile|
Safety and Handling
EINECSNumber : 200-835-2
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.Ok
CERILLIANT is a registered trademark of Cerilliant Corporation